Mu Opioid Receptor 1 (MOR-1) Expression in Colorectal Cancer and Oncological Long-Term Outcomes: A Five-Year Retrospective Longitudinal Cohort Study

Preclinical evidence has shown increased expression of mu opioid receptor 1 (MOR-1) in colorectal cancer although its association with disease-free and overall survival (DFS and OS) has not been investigated. We hypothesized that MOR-1 was overexpressed in tumor samples compared to normal tissue and...

Descripción completa

Detalles Bibliográficos
Autores principales: Díaz-Cambronero, Oscar, Mazzinari, Guido, Giner, Francisco, Belltall, Amparo, Ruiz-Boluda, Lola, Marqués-Marí, Anabel, Sánchez-Guillén, Luis, Eroles, Pilar, Cata, Juan Pablo, Argente-Navarro, María Pilar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016725/
https://www.ncbi.nlm.nih.gov/pubmed/31948099
http://dx.doi.org/10.3390/cancers12010134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016725/
https://www.ncbi.nlm.nih.gov/pubmed/31948099
http://dx.doi.org/10.3390/cancers12010134

Ejemplares similares